Immunology

Chronic adverse effects from anti-PD-1 immunotherapies common

(HealthDay)—Chronic immune-related adverse effects after adjuvant treatment with anti-programmed cell death 1 (anti-PD-1) immunotherapies for melanoma are more common than previously thought, according to a study published ...

page 1 from 16